Interesting BTI Put And Call Options For February 2026

The piece outlines two option strategies on British American Tobacco (BTI, current price $56.47): selling a $55 put (bid $1.70) which nets an effective purchase basis of $53.30 and carries a 61% probability of expiring worthless, equating to a 3.09% return on cash or 17.91% annualized if it does; and selling a $60 covered call (bid $0.80) on shares bought at $56.47 that would produce a 7.67% total return if called at Feb 2026 or a 1.42% premium boost (8.21% annualized) if the call expires worthless with a 73% probability. Implied volatilities are 26% for the put and 23% for the call versus a trailing 12-month volatility of 22%, framing the risk/reward and chance of assignment for investors evaluating yield-enhancement trades.

Analysis

Market structure: Short-dated option income strategies on BTI benefit retail/income sellers and market-makers collecting theta; institutional buyers of yield (covered-call/put-sell) are incremental marginal demand that marginally compresses implied vol (puts 26% vs realized 22%). Direct losers are long upside speculators who get capped by covered calls and anyone forced into shares at assignment if regulation shocks occur; overall market share/power of BTI unchanged by these option flows but price discovery tightens around the $53–60 band over the next 6–8 weeks.

Risk assessment: Tail risks are regulatory (EU/UK flavor/tax moves, FDA guidance) or litigation shocks that can trigger 20–40% downside in weeks — treat these as low-probability, high-impact events over 3–12 months. Near-term (days–weeks) risks are IV spikes or early assignment around ex-dividend dates; medium-term (months) risks are excise/tax announcements and FX moves (GBP/USD ~±5% can move ADRs). Hidden dependencies include dividend sustainability and cross-border settlement (ADS vs ordinary shares) which can produce unexpected assignment timing.

Trade implications: Implement defined-risk credit trades: sell Feb-2026 BTI 55 put for ~1.70 while buying the 50 put to create a 55/50 bull put spread (max loss = 350 - premium) sized to 1–3% portfolio risk; alternatively buy BTI and sell Feb-2026 60 call (covered call) to lock ~7.7% capped return to expiry. Consider pair trade long BTI vs short PM (Philip Morris, PM) if you prefer relative value: overweight BTI by 1–2% vs underweight PM if BTI dividend yield + buyback support > PM on a 6–12 month view.

Contrarian angles: Consensus treats these as vanilla income plays but underestimates regulatory tail risk and currency exposure; the put IV premium (26% vs realized 22%) implies ~4-point risk premium — not huge, suggesting limited fear priced in. Historical parallels (tobacco shocks 2008–2015) show 30%+ drawdowns recover over years if pricing power holds; beware of assignment concentration and use spreads or size limits to avoid forced accumulation.

Key Decisions for Investors

• Sell-to-open BTI Feb-2026 55 put and simultaneously buy Feb-2026 50 put to form a 55/50 bull-put credit spread for ~net credit (target ~1.00–1.20); size so max loss equals 1–2% of portfolio and close/hedge if BTI <51 or IV>35%.
• Establish a covered-call stance: buy BTI around $56.47 and sell Feb-2026 60 call (collect ~0.80) for a capped 7.7% return to expiry; limit allocation to 1–3% of equity and buy a Feb-2026 55 protective put if downside protection desired (cost threshold <1.5%).
• Relative-value: go long BTI (2% notional) and short PM (2% notional) if BTI dividend yield > PM by >100bps and you expect price convergence in 6–12 months; unwind if spread widens by >10% or on regulatory announcements.
• Risk-control: do not naked-sell puts >2% portfolio exposure; monitor EU/UK regulatory notices and GBP/USD moves over next 30–90 days and liquidate or hedge positions if a major regulatory draft is published or GBP moves >3% vs USD intraday.